why choose us

First received: August 8, 2022

Clinical Trial: Characteristics of Patients With Sickle Cell Disease

Study Status: Completed

Recruit Status: Completed

Condition: Sickle Cell Disease

Study Type: Observational


Official Title: Characteristics of Patients With Sickle Cell Disease Who Initiate Crizanlizumab Therapy

Brief Summary: This was a retrospective descriptive analysis of health care claims data using the IQVIA open source medical and pharmacy claims databases.

Read more